✦ LIBER ✦

A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei

✍ Scribed by Farquharson, A L; Pranesh, N; Witham, G; Swindell, R; Taylor, M B; Renehan, A G; Rout, S; Wilson, M S; O'Dwyer, S T; Saunders, M P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitomycin-C and capecitabine as third-li

✍ Do Hyoung Lim; Young Suk Park; Byeong-Bae Park; Sang Hoon Ji; Jeeyun Lee; Keon W 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Phase II study of capecitabine and mitom

✍ Rao, S; Cunningham, D; Price, T; Hill, M E; Ross, P J; Tebbutt, N; Norman, A R; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

Phase II study of concurrent chemoradiot

✍ Kim, J G; Sohn, S K; Kim, D H; Baek, J H; Jeon, S B; Chae, Y S; Lee, K B; Park, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

O2. Phase II study of concurrent chemora

✍ G.-B. Adilbaev; G. Kidirbaeva; A.-D. Savhatova; A.-O. Turesheva; D.-G. Adilbay 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Radiation Therapy Oncology Group 0247: A

✍ Stuart J. Wong; Kathryn Winter; Neal J. Meropol; Pramila Rani Anne; Lisa Kachnic 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 333 KB

260 A phase II study of preoperative oxa

✍ B. Honhon; L. Duck; B. Coster; J.-C. Coche; J.-L. Canon; P. Scalliet; C. Sempoux 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB